Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
CPhI & P-MEC China to host 'Virtual Expo Connect' in June
2020-04-30 19:13
WuXi Biologics and Aravive Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies Targeting Cancer and Fibrosis Using the WuXiBody™ Platform
2020-04-30 19:00
INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data With DNA Vaccine INO-4700 for MERS Coronavirus at the American Society of Gene & Cell Therapy (ASGCT) Conference
2020-04-29 04:30
INOVIO Completes Enrollment in the Phase 1 U.S. Trial of INO-4800 for COVID-19 DNA Vaccine; Interim Results Expected in June
2020-04-28 20:00
PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19
2020-04-28 18:57
Insilico Medicine enters into a collaboration research with Astellas Pharma Inc. to apply novel generative artificial intelligence system for a conventionally challenging target family
2020-04-28 08:46
Berkeley Lights Launches Two New Capabilities in the Opto Cell Therapy Development 1.0 Workflow to Accelerate the Creation Of Effective Cancer Immunotherapies
2020-04-28 00:00
Lianhua Qingwen Approved and Registered by Ministry of Public Health of Ecuador as Natural Medicine
2020-04-27 20:43
Menarini Silicon Biosystems Explores New Application for Circulating Endothelial Cells in COVID-19
2020-04-27 20:10
Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate's International, Phase III Clinical Study
2020-04-27 16:34
AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine
2020-04-24 14:50
Innovent and Eli Lilly Announce NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum as First-Line Therapy in Non-squamous NSCLC
2020-04-24 07:50
First Patient in Treatment in RhoVac's Clinical Phase IIb Study in Germany
2020-04-24 00:37
Henlius receives EU GMP Certificate for HLX02 (Trastuzumab for Injection)
2020-04-23 22:02
Lianhua Qingwen Listed in the Novel Coronavirus Pneumonia Diagnosis and Treatment Scheme for Laos
2020-04-23 20:00
Signifier Medical Technologies Collaborates With Global Sleep Experts on Its Innovative Snoozeal(R) Device Clinical Trials
2020-04-23 19:00
Luye Pharma Group Selects LifeSphere® Signal and Risk Management to Automate Drug Safety Signal Detection
2020-04-23 13:00
New Early Breast Cancer Drug Available Now In Singapore
2020-04-23 12:33
Bugworks Raises US$7.5M From a Global Investment Syndicate to Combat the Global Challenge Posed by Deadly Bacterial Superbugs
2020-04-23 11:30
OncoQuest Announces Signing of a Definitive Agreement to Sell Drug Portfolio to Dual Industrial for U.S. $300 Million and Commitment to Fund the Oregovomab Phase 3 Clinical Trial in Frontline Ovarian Cancer
2020-04-23 01:38
1
181
182
183
184
185
253